Drug Shortage Report for HYDROMORPHONE HP 50
Report ID | 164207 |
Drug Identification Number | 02146126 |
Brand name | HYDROMORPHONE HP 50 |
Common or Proper name | HYDROMORPHONE HP 50 |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1ML 10LIVI |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-07-06 |
Estimated end date | 2022-10-14 |
Actual end date | 2022-10-19 |
Shortage status | Resolved |
Updated date | 2022-10-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2022-10-20 | English | Compare |
v12 | 2022-10-19 | French | Compare |
v11 | 2022-10-19 | English | Compare |
v10 | 2022-10-04 | French | Compare |
v9 | 2022-10-04 | English | Compare |
v8 | 2022-08-18 | French | Compare |
v7 | 2022-08-18 | English | Compare |
v6 | 2022-08-03 | French | Compare |
v5 | 2022-08-03 | English | Compare |
v4 | 2022-07-07 | English | Compare |
v3 | 2022-07-06 | French | Compare |
v2 | 2022-07-06 | English | Compare |
v1 | 2022-07-06 | English | Compare |
Showing 1 to 13 of 13